Page 1216 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

73. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of 92. Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E,
status epilepticus in adults: a study of 13 episodes. Eur Neurol. Skaar DJ. Treatment of refractory status epilepticus with
2005;54:34-38. propofol: clinical and pharmacokinetic findings. Epilepsia.
74. Rossetti AO, Bromfield EB. Determinants of success in the 1998;39:18-26.
use of oral levetiracetam in status epilepticus. Epilepsy Behav. 93. Krishnamurthy KB, Drislane FW. Relapse and survival after
2006;8:651-654. barbiturate anesthetic treatment of refractory status epilepticus.
75. Knake S, Gruener J, Hattemer K, et al. Intravenous levetirace- Epilepsia. 1996;37:863-867.
tam in the treatment of benzodiazepine refractory status epilep- 94. Kumar M, Khaled KA, Urrutia VC, et al. Irreversible acidosis
ticus. J Neurol Neurosurg Psychiatry. 2008;79:588-589. and death after prolonged propofol infusion use in two adult
76. Milligan TA, Hurwitz S, Bromfield EB. Efficacy and tolerability patients: propofol infusion syndrome in adults revisited. In:
of levetiracetam versus phenytoin after supratentorial neurosur- Neurocritical Care Society Meeting. San Diego, CA; 2004.
gery. Neurology. 2008;71:665-669. 95. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associ-
77. Berning S, Boesebeck F, van Baalen A, Kellinghaus C. ated with prolonged propofol infusion in children. Neurology.
Intravenous levetiracetam as treatment for status epilepticus. 1998;50:301-303.
J Neurol. 2009;256:1634-1642. 96. Hanley DF Jr, Pozo M. Treatment of status epilepticus with mid-
78. Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera azolam in the critical care setting. Int J Clin Pract. 2000;54:30-35.
MD, Yates SL. Levetiracetam use in critically ill patients. 97. Igartua J, Silver P, Maytal J, Sagy M. Midazolam coma for refrac-
Neurocrit Care. 2007;7:140-147. tory status epilepticus in children. Crit Care Med. 1999;27:
79. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, 1982-1985.
randomized, single-blinded comparative trial of intrave- 98. Kumar A, Bleck TP. Intravenous midazolam for the treatment of
nous levetiracetam versus phenytoin for seizure prophylaxis. refractory status epilepticus. Crit Care Med. 1992;20:483-488.
Neurocrit Care. 2010;12:165-172. 99. Shafer A. Complications of sedation with midazolam in the
80. Shah D, Husain AM. Utility of levetiracetam in patients with intensive care unit and a comparison with other sedative regi-
subarachnoid hemorrhage. Seizure. 2009;18:676-679. mens. Crit Care Med. 1998;26:947-956.
81. Bleck TP. Management approaches to prolonged seizures 100. Naritoku DK, Sinha S. Prolongation of midazolam half-life
and status epilepticus. Epilepsia. 1999;40(suppl 1):S59-S63; after sustained infusion for status epilepticus. Neurology.
discussion S4-S6. 2000;54:1366-1368.
82. Treiman DM, Meyers PD, Walton NY, et al. A comparison of 101. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on
four treatments for generalized convulsive status epilepticus. the management of status epilepticus in adults. Eur J Neurol.
Veterans Affairs Status Epilepticus Cooperative Study Group. 2010;17:348-355.
N Engl J Med. 1998;339:792-798. 102. Swisher CB, Doreswamy M, Gingrich KJ, Vredenburgh JJ,
83. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular Kolls BJ. Phenytoin, levetiracetam, and pregabalin in the acute
versus intravenous therapy for prehospital status epilepticus. management of refractory status epilepticus in patients with
N Engl J Med. 2012;366:591-600. brain tumors. Neurocrit Care. 2012;16:109-113.
84. Krakow K, Walker M, Otoul C, Sander JW. Long-term con- 103. Kellinghaus C. Lacosamide as treatment for partial epilepsy:
tinuation of levetiracetam in patients with refractory epilepsy. mechanisms of action, pharmacology, effects, and safety. Ther
Neurology. 2001;56:1772-1774. Clin Risk Manag. 2009;5:757-766.
85. Moddel G, Bunten S, Dobis C, et al. Intravenous levetiracetam: 104. Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS.
a new treatment alternative for refractory status epilepticus. Intravenous lacosamide in refractory nonconvulsive status epi-
J Neurol Neurosurg Psychiatry. 2009;80:689-692. lepticus. Seizure. 2012;21(3):198-201.
86. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors 105. Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin
and prognosis of refractory status epilepticus treated in a neu- JJ III. The use of lacosamide in refractory status epilepticus.
rological intensive care unit. J Neurol Neurosurg Psychiatry. Neurocrit Care. 2011;14:348-353.
2005;76:534-539. 106. Shorvon S. Super-refractory status epilepticus: an approach
87. Krishnamurthy KB, Drislane FW. Depth of EEG suppression to therapy in this difficult clinical situation. Epilepsia.
and outcome in barbiturate anesthetic treatment for refractory 2011;52(suppl 8):53-56.
status epilepticus. Epilepsia. 1999;40:759-762. 107. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for
88. Bleck TP. Intensive care unit management of patients with status refractory status epilepticus. Neurocrit Care. 2008;9:189-197.
epilepticus. Epilepsia. 2007;48(suppl 8):59-60. 108. Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E.
89. Power KN, Flaatten H, Gilhus NE, Engelsen BA. Propofol treat- Lorazepam versus diazepam in the acute treatment of epi-
ment in adult refractory status epilepticus. Mortality risk and leptic seizures and status epilepticus. Dev Med Child Neurol.
outcome. Epilepsy Res. 2011;94:53-60. 1995;37:682-688.
90. Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol 109. Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in
in status epilepticus: little evidence, many dangers? J Neurol. the treatment of status epilepticus in children. Crit Care Med.
2003;250:1237-1240. 1993;21:991-994.
91. Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and 110. Sheth RD, Buckley DJ, Gutierrez AR, Gingold M, Bodensteiner
midazolam in the treatment of refractory status epilepticus. JB, Penney S. Midazolam in the treatment of refractory neonatal
Epilepsia. 2001;42:380-386. seizures. Clin Neuropharmacol. 1996;19:165-170.

Section06-O-ref.indd 3 12/10/2014 6:03:39 PM